Liquidia Corporation (NASDAQ:LQDA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, five have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $75.23.
LQDA has been the subject of several research analyst reports. Wall Street Zen downgraded shares of Liquidia from a "buy" rating to a "hold" rating in a research report on Saturday, October 3rd. Citigroup reaffirmed a "neutral" rating on shares of Liquidia in a report on Thursday, October 1st. Needham & Company LLC lifted their price target on Liquidia from $58.00 to $66.00 and gave the company a "buy" rating in a research note on Wednesday, November 11th. Piper Sandler set a $129.00 price objective on Liquidia in a research report on Friday, July 24th. Finally, Zacks Research raised Liquidia from a "strong sell" rating to a "hold" rating in a research note on Thursday, November 12th.
Get Our Latest Report on LQDA
Liquidia Price Performance
LQDA stock opened at $56.37 on Tuesday. The company has a quick ratio of 2.12, a current ratio of 1.02 and a debt-to-equity ratio of 0.63. Liquidia has a 12 month low of $22.31 and a 12 month high of $93.61. The firm has a market cap of $5.08 billion, a P/E ratio of -45.83, a P/E/G ratio of 1.39 and a beta of 0.40. The company's 50-day moving average price is $48.72 and its two-hundred day moving average price is $54.82.
Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings results on Tuesday, November 10th. The company reported ($2.64) earnings per share for the quarter, missing analysts' consensus estimates of $0.96 by ($3.60). The firm had revenue of $225.30 million for the quarter, compared to the consensus estimate of $214.18 million. Liquidia had a positive return on equity of 264.65% and a negative net margin of 15.15%. The business's revenue was up 314.9% on a year-over-year basis. During the same period last year, the company posted ($0.04) EPS. On average, analysts anticipate that Liquidia will post -0.25 earnings per share for the current fiscal year.
Insider Buying and Selling at Liquidia
In related news, insider Rajeev Saggar sold 50,000 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $74.06, for a total transaction of $3,703,000.00. Following the completion of the transaction, the insider directly owned 142,265 shares in the company, valued at $10,536,145.90. This represents a 26.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Katherine Rielly-Gauvin sold 36,789 shares of the stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $74.99, for a total value of $2,758,807.11. Following the completion of the transaction, the director owned 44,637 shares of the company's stock, valued at $3,347,328.63. The trade was a 45.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 537,045 shares of company stock worth $23,476,727 over the last 90 days. 25.60% of the stock is owned by corporate insiders.
Institutional Trading of Liquidia
A number of institutional investors have recently bought and sold shares of the company. Pinnacle Wealth Planning Services Inc. grew its holdings in Liquidia by 26.2% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the period. Sterling Capital Management LLC lifted its stake in Liquidia by 839.1% during the 3rd quarter. Sterling Capital Management LLC now owns 2,329 shares of the company's stock valued at $70,000 after acquiring an additional 2,081 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in Liquidia by 13.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company's stock valued at $80,000 after acquiring an additional 320 shares in the last quarter. Globeflex Capital L P purchased a new position in Liquidia during the 2nd quarter worth $175,000. Finally, Nykredit A S purchased a new position in Liquidia during the second quarter worth about $177,000. Institutional investors own 64.54% of the company's stock.
Liquidia Company Profile
(
Get Free Report)
Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing treatments for pulmonary hypertension and other serious diseases. Its work includes inhaled therapies designed to deliver medicines to the lungs. The company's marketed product, Yutrepia (treprostinil) inhalation powder, is approved in the United States for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Liquidia also has a pipeline of investigational therapies, including other formulations of treprostinil.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Liquidia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.
While Liquidia currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.